Overview

Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectivity and safety of atrial fibrillation ablation, in comparison to antiarrhythmic drug therapy in patients with refractory, persistent atrial fibrillation.
Phase:
Phase 4
Details
Lead Sponsor:
Hospital Clinic of Barcelona
Collaborators:
Biosense Webster, Inc.
Fundacio Clinic
Fundacio Clinic Barcelona
Medtronic
Treatments:
Anti-Arrhythmia Agents